Compare RMAX & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RMAX | MBOT |
|---|---|---|
| Founded | 1973 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.2M | 145.7M |
| IPO Year | 2013 | 2000 |
| Metric | RMAX | MBOT |
|---|---|---|
| Price | $6.30 | $2.38 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $9.00 | $7.50 |
| AVG Volume (30 Days) | 210.9K | ★ 2.1M |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 30.48 |
| EPS | ★ 0.60 | N/A |
| Revenue | ★ $195,929,000.00 | $116,887.00 |
| Revenue This Year | $3.48 | N/A |
| Revenue Next Year | $3.89 | $4,186.27 |
| P/E Ratio | $10.86 | ★ N/A |
| Revenue Growth | ★ 11.13 | N/A |
| 52 Week Low | $6.23 | $1.25 |
| 52 Week High | $10.32 | $4.62 |
| Indicator | RMAX | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 29.19 | 59.93 |
| Support Level | $6.23 | $2.34 |
| Resistance Level | $8.47 | $2.68 |
| Average True Range (ATR) | 0.31 | 0.20 |
| MACD | -0.06 | 0.06 |
| Stochastic Oscillator | 4.17 | 68.23 |
RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises. The company's operating segments include Real Estate, Mortgage, Marketing Funds, and Others. It generates maximum revenue from the Real Estate segment.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.